Zenrax Healthcare India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -42.24%
- Profit Growth 38.14%
- Ebitda 32.08%
- Net Worth -36.95%
- Total Assets 10.65%
About Zenrax Healthcare India
Zenrax Healthcare India Private Limited (ZHIPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 October 2015 (Nine years and three months 27 days old ). Its registered office is in Bhopal, Madhya Pradesh, India.
The Corporate was formerly known as Zenrax Medicos India Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Vinay Swami, Swapnil Swami, and Manish Upadhyay serve as directors at the Company.
Company Details
-
Location
Bhopal, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MP2015PTC034838
-
Company No.
034838
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Oct 2015
-
Date of AGM
31 Dec 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Zenrax Healthcare India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Swami
|
Director | 15-Oct-2015 | Current |
|
Swapnil Swami
|
Director | 15-Oct-2015 | Current |
|
Manish Upadhyay
|
Director | 17-Dec-2015 | Current |
Financial Performance of Zenrax Healthcare India.
Zenrax Healthcare India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 42.24% decrease. The company also saw a substantial improvement in profitability, with a 38.14% increase in profit. The company's net worth observed a substantial decline by a decrease of 36.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenrax Healthcare India?
In 2016, Zenrax Healthcare India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zenrax Healthcare India?
Unlock and access historical data on people associated with Zenrax Healthcare India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenrax Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenrax Healthcare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
